An unusual case of recurrent emesis in a patient with autistic disorder

Mental Health Aspects of Developmental Disabilities

Volumn 8, Issue 1, 2005, Pages 1-4

  Curtis, Klara ^a,b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Jacksonville Developmental Center   (United States)

Author keywords

Autism; Developmental disabilities; Eating disorder; Fluvoxamine; Intellectual disability; Mental retardation; OCD; Psychiatric

Indexed keywords

CHLORPROMAZINE; CISAPRIDE; FLUVOXAMINE; NALTREXONE; OMEPRAZOLE; PROCHLORPERAZINE MALEATE; RANITIDINE; SERTRALINE;

ADULT; ANAMNESIS; ARTICLE; AUTISM; BODY WEIGHT; CASE REPORT; CLINICAL FEATURE; DIET THERAPY; DISEASE CONTROL; DISEASE SEVERITY; DOSE RESPONSE; DRUG MEGADOSE; ESOPHAGUS DISEASE; FEEDING APPARATUS; FOOD INTAKE; GASTROESOPHAGEAL REFLUX; HIATUS HERNIA; HUMAN; INTELLECTUAL IMPAIRMENT; MALE; MEDICAL ASSESSMENT; RECURRENT DISEASE; REFRACTORY PERIOD; STOMACH FUNDOPLICATION; TREATMENT OUTCOME; UNDERWEIGHT; VOMITING;

EID: 15744386577     PISSN: 10573291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Gallucci G, Andersen A, Hackerman F, Mondimore F. Eating and feeding difficulties in patients with intellectual and developmental disabilities: Four cases. Ment Health Aspects Dev Disabil 2003;6:114-119.
2. Hove O. Prevalence of eating disorders in adults with mental retardation living in the community. Am J Ment Retard 2004;109:501-506.
3. Johnson JG, Cohen P, Kasen S, Brook J. Childhood adversities associated with risk for eating disorders or weight problems during adolescence or early adulthood. Am J Psychiatry 2002;159:394-400.
4. Marrazzi MA, Bacon JP, Kinzie J, Luby ED. Naltrexone use in the treatment of anorexia nervosa and bulimia nervosa. Int Clin Psychopharmacol 1995;10:163-172.
5. Marrazzi MA, Kinzie J, Luby ED. A detailed longitudinal analysis on the use of naltrexone in the treatment of bulimia. Int Clin Psychopharmacol 1995;10:173-176.
6. McDougle CJ, Naylor ST, Cohen DJ, et al. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry 1996;53:1001-1008.